Updated:
Tabula Rasa HealthCare
We are medication experts, delivering an unparalleled combination of integrated clinical pharmacy and technology solutions that optimize care and outcomes for...
Tabula Rasa HealthCare
We are medication experts, delivering an unparalleled combination of integrated clinical pharmacy and technology solutions that optimize care and outcomes for people with the most complex, chronic care needs and the healthcare organizations that care for them.
General information
Firm type
other
Location
Region
North America
Country
United States
City
Moorestown
Corporate office
Moorestown, NJ, United States
Sector focus
Frequently asked questions
Who controls Tabula Rasa HealthCare?
Tabula Rasa HealthCare's ownership and control structure are not publicly disclosed. The firm's website does not list principals or investors. Its classification in family-office research stems from potential private ownership, but no verified information is available (Altss research).
What does Tabula Rasa HealthCare do?
The firm provides integrated clinical pharmacy and technology solutions to optimize medication management for patients with complex chronic care needs. It serves healthcare organizations and works on quality metrics like Medicare Star Ratings (per the firm's website).
Where is Tabula Rasa HealthCare based?
The company is headquartered in Moorestown, New Jersey, United States. No additional offices are listed on its website or in public records (Altss research).
Does Tabula Rasa HealthCare invest in other companies?
Tabula Rasa HealthCare appears to be an operating company, not an investment entity. There is no public evidence of it making external investments or managing a portfolio of companies. Its activities are focused on its own healthcare services (Altss research).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: